LeonaBio, Inc. (LONA) stock
LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.65−0.11 (-3.99%)
Close on Nov 18, 2026Market cap $24.97MP/E –Yield –
LeonaBio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
LeonaBio's enterprise value was -$14.51M on Nov 11, 2026, against -$8.07M a year earlier. Over the last 5 years it ranged from -$148.77M to $250.91M, with a median of -$35.24M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$14.51M | -413.5% |
| 2025 | Dec 31, 2025 | $4.63M | – |
| 2024 | Dec 31, 2024 | -$46.17M | – |
| 2023 | Dec 29, 2023 | -$80.48M | – |
| 2022 | Dec 30, 2022 | -$101.08M | -140.3% |
| 2021 | Dec 31, 2021 | $250.91M | -70.1% |
| 2020 | Dec 31, 2020 | $838.47M | – |
See a number that looks wrong?